Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands

Mirjam J Knol; Gertjan H J Wagenvoort; Elisabeth A M Sanders; Karin Elberse; Bart J Vlaminckx; Hester E de Melker; Arie van der Ende

doi:10.3201/eid2111.140780

Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands

Mirjam J Knol, Gertjan H J Wagenvoort, Elisabeth A M Sanders, Karin Elberse, Bart J Vlaminckx, Hester E de Melker, Arie van der Ende

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Three years after a 7-valent pneumococcal conjugate vaccine was replaced by a 10-valent pneumococcal conjugate vaccine in the Netherlands, we observed a decrease in incidence of invasive pneumococcal disease caused by Streptococcus pneumoniae serotypes 1, 5, and 7F. Our data do not support or exclude cross-protection against serotype 19A.

Original language	English
Pages (from-to)	2040-2044
Number of pages	5
Journal	Emerging Infectious Diseases
Volume	21
Issue number	11
DOIs	https://doi.org/10.3201/eid2111.140780
Publication status	Published - Nov 2015

Keywords

RANDOMIZED-CONTROLLED-TRIAL
PHID-CV
IMMUNOGENICITY

Access to Document

10.3201/eid2111.140780Licence: CC BY

14-0780Final published version, 1.71 MBLicence: CC BY

Cite this

@article{f7a2bf45b997493796e47f08c4d04534,

title = "Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands",

abstract = "Three years after a 7-valent pneumococcal conjugate vaccine was replaced by a 10-valent pneumococcal conjugate vaccine in the Netherlands, we observed a decrease in incidence of invasive pneumococcal disease caused by Streptococcus pneumoniae serotypes 1, 5, and 7F. Our data do not support or exclude cross-protection against serotype 19A.",

keywords = "RANDOMIZED-CONTROLLED-TRIAL, PHID-CV, IMMUNOGENICITY",

author = "Knol, {Mirjam J} and Wagenvoort, {Gertjan H J} and Sanders, {Elisabeth A M} and Karin Elberse and Vlaminckx, {Bart J} and {de Melker}, {Hester E} and {van der Ende}, Arie",

year = "2015",

month = nov,

doi = "10.3201/eid2111.140780",

language = "English",

volume = "21",

pages = "2040--2044",

journal = "Emerging Infectious Diseases",

issn = "1080-6040",

publisher = "Centers for Disease Control and Prevention (CDC)",

number = "11",

}

TY - JOUR

T1 - Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands

AU - Knol, Mirjam J

AU - Wagenvoort, Gertjan H J

AU - Sanders, Elisabeth A M

AU - Elberse, Karin

AU - Vlaminckx, Bart J

AU - de Melker, Hester E

AU - van der Ende, Arie

PY - 2015/11

Y1 - 2015/11

N2 - Three years after a 7-valent pneumococcal conjugate vaccine was replaced by a 10-valent pneumococcal conjugate vaccine in the Netherlands, we observed a decrease in incidence of invasive pneumococcal disease caused by Streptococcus pneumoniae serotypes 1, 5, and 7F. Our data do not support or exclude cross-protection against serotype 19A.

AB - Three years after a 7-valent pneumococcal conjugate vaccine was replaced by a 10-valent pneumococcal conjugate vaccine in the Netherlands, we observed a decrease in incidence of invasive pneumococcal disease caused by Streptococcus pneumoniae serotypes 1, 5, and 7F. Our data do not support or exclude cross-protection against serotype 19A.

KW - RANDOMIZED-CONTROLLED-TRIAL

KW - PHID-CV

KW - IMMUNOGENICITY

UR - http://www.scopus.com/inward/record.url?scp=84944531762&partnerID=8YFLogxK

U2 - 10.3201/eid2111.140780

DO - 10.3201/eid2111.140780

M3 - Article

C2 - 26488415

SN - 1080-6040

VL - 21

SP - 2040

EP - 2044

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

IS - 11

ER -

Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this